JUPITER, Fla. - eTradeWire -- DG Magnetics R&D LLC Announces Issuance of Second U.S. Patent Award,
Expanding Its Electromagnetic Technology Portfolio

DG Magnetics R&D LLC. (MagnaPuncture.com) announces the issuance of its second United States patent, U.S. Patent No. 12,667,520, granted by the United States Patent and Trademark Office (USPTO) on June 30, 2026.

This newly granted patent emerged as an offshoot of research associated with the company's earlier intellectual property, yet represents a unique electromagnetic technology with much broader, far-reaching commercial applications.

The company's latest patent breaks new ground by applying well established electrical principles in a novel configuration. This unusual patent changes the way magnetic coils are energized and improves overall coil efficiency by dramatically reducing the coil's impedance. This spectacular reduction in resistance also reduces unwanted heat normally generated as a byproduct when energized. While this unique method does not create superconductivity per se, it does deliver room-temperature performance approaching levels which would otherwise be associated with superconducting coils. Furthermore, it appears quite possible that retrofitting this technology to very large or difficult to replace coils can often be accomplished in situ.

"Receiving this second U.S. patent represents an important milestone in the expansion of our intellectual property portfolio," said Dennis Marcantonio, Co-Inventor and Principal of DG Magnetics R&D LLC.. "Our original objective was to develop an engineering framework for organizing and delivering externally applied electromagnetic fields, in combination with light and sound across related physiologic pathways. In simpler terms, we set out to introduce 21st-century technology to a practice with roots extending back many thousands of years. What we did not anticipate, was how that research would take an unexpected turn and lead to an amazing discovery involving how electromagnetic coils themselves can be energized in exciting new ways. That offshoot has now resulted in our second patent and opens an entirely new range of potential commercial applications."

More on eTradeWire News

• Local Ecomaids Owner Launches Healthy Home Reset Initiative for Triangle Families
• Qscription Technologies and NEOPATHOLOGY CORP. Sign MOU to Bring FDA-Cleared Lung Imaging AI into U.S. Clinical Practice
• 2025 R&D Spending And Intensity Benchmarks
• Beucher Insurance Agency Becomes Diamond Sponsor of Mt. Dora Christian Academy
• Central Florida Bonding Publishes New Guide on What Happens After a Warrant Arrest

Co-Inventor Greg N. Bartosiewicz, BSMLS, MAcCHM, added: "Innovation increasingly depends upon the combination of rigorous engineering and strong intellectual property. This second patent grew out of years of incremental developments that steadily improved MagnaPuncture®, and its potential applications extend well beyond our original wellness technology.

"MagnaPuncture®, the product of our first patent, was originally developed as a wellness platform intended to enhance the effectiveness and extend the benefits of acupuncture treatments, as illustrated on Absolutewellnessspa.com. Long-term clinical use in our practice have produced encouraging results both as an adjunct to acupuncture, and even shown effectiveness when employed as a standalone wellness treatment. Its coordinated electromagnetic field configurations, combined with light and sound, also provide a platform for continued research across neuromodulation, rehabilitation, integrative medicine, human performance, and wellness applications. The company's first patent, U.S. Patent No. 11,344,738 B2, established the foundational architecture for its MagnaPuncture® technology."

"The patented MagnaPuncture® system, is designed around coordinated, non-invasive electromagnetic field delivery across anatomically and functionally related pathways, with complementary light and sound modalities. Its distributed approach coordinates stimulation across multiple anatomical targets rather than relying solely on isolated point-by-point treatment. MagnaPuncture® may also provide a complementary direction within the broader field of neuromodulation. While many established neuromodulation technologies target central or spinal neural structures through implanted or procedure-based systems, MagnaPuncture® is designed to engage distributed peripheral neuro-fascial pathways externally. This unique distinction creates new opportunities to employ our platform as an adjunct to established neuromodulation and rehabilitation strategies, including the potential for appropriately supervised supportive use in outpatient and, where suitable, home-based settings."

More on eTradeWire News

• L3 Consulting Strengthens IT Support and Cyber Security Services for Adelaide Businesses
• NITE-E-NIGHT: The Future of Gaming Is Live
• OLENPHOGY Targets Nighttime Recovery with Sleep-Cortisol Inositol Complex
• SULAAH Magazine Announces Fractured Atlas Fiscal Sponsorship for Lost Files
• Award-Winning Australian Pet Innovation Company Expands into America Through Chewy

Forward-Looking Statement

DG Magnetics R&D LLC views its expanding patent portfolio as a strategic asset. The company expects to continue developing these and other technologies through engineering studies, prototype development, product refinements, licensing initiatives, and technology partnerships. As a growing company, DG Magnetics R&D LLC remains open to working with qualified organizations in pursuit of innovative, mutually beneficial commercial opportunities.

This release contains forward-looking statements regarding technology development, intellectual property, commercialization opportunities, licensing activities, strategic partnerships, and potential future applications. These statements reflect the company's current expectations and are based on information available as of the date of this release. Actual results, developments, or outcomes may differ materially due to technical, commercial, financial, regulatory, or other factors. DG Magnetics R&D LLC undertakes no obligation to update or revise these forward-looking statements except as may be required by applicable law.
DG Magnetics R&D LLC website: MagnaPuncture.com